CADL
Price
$6.14
Change
-$0.17 (-2.69%)
Updated
Sep 6 closing price
61 days until earnings call
MDGL
Price
$243.89
Change
-$2.11 (-0.86%)
Updated
Sep 6 closing price
60 days until earnings call
Ad is loading...

CADL vs MDGL

Header iconCADL vs MDGL Comparison
Open Charts CADL vs MDGLBanner chart's image
Candel Therapeutics
Price$6.14
Change-$0.17 (-2.69%)
Volume$143.91K
CapitalizationN/A
Madrigal Pharmaceuticals
Price$243.89
Change-$2.11 (-0.86%)
Volume$222.46K
CapitalizationN/A
View a ticker or compare two or three
CADL vs MDGL Comparison Chart
Loading...
CADL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MDGL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
CADL vs. MDGL commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CADL is a Hold and MDGL is a Hold.

COMPARISON
Comparison
Sep 08, 2024
Stock price -- (CADL: $6.30 vs. MDGL: $246.11)
Brand notoriety: CADL and MDGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CADL: 75% vs. MDGL: 70%
Market capitalization -- CADL: $197M vs. MDGL: $5.3B
CADL [@Biotechnology] is valued at $197M. MDGL’s [@Biotechnology] market capitalization is $5.3B. The market cap for tickers in the [@Biotechnology] industry ranges from $584.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.98B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CADL’s FA Score shows that 0 FA rating(s) are green whileMDGL’s FA Score has 0 green FA rating(s).

  • CADL’s FA Score: 0 green, 5 red.
  • MDGL’s FA Score: 0 green, 5 red.
According to our system of comparison, MDGL is a better buy in the long-term than CADL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CADL’s TA Score shows that 6 TA indicator(s) are bullish while MDGL’s TA Score has 5 bullish TA indicator(s).

  • CADL’s TA Score: 6 bullish, 4 bearish.
  • MDGL’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CADL is a better buy in the short-term than MDGL.

Price Growth

CADL (@Biotechnology) experienced а -1.25% price change this week, while MDGL (@Biotechnology) price change was -1.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.71%. For the same industry, the average monthly price growth was +3.67%, and the average quarterly price growth was -3.87%.

Reported Earning Dates

CADL is expected to report earnings on Nov 07, 2024.

MDGL is expected to report earnings on Nov 06, 2024.

Industries' Descriptions

@Biotechnology (-2.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MDGL($5.3B) has a higher market cap than CADL($197M). CADL YTD gains are higher at: 328.571 vs. MDGL (6.366). CADL has higher annual earnings (EBITDA): -46.44M vs. MDGL (-494.77M). MDGL has more cash in the bank: 1.06B vs. CADL (21.5M). CADL has less debt than MDGL: CADL (18.6M) vs MDGL (118M). MDGL has higher revenues than CADL: MDGL (14.6M) vs CADL (0).
CADLMDGLCADL / MDGL
Capitalization197M5.3B4%
EBITDA-46.44M-494.77M9%
Gain YTD328.5716.3665,161%
P/E RatioN/AN/A-
Revenue014.6M-
Total Cash21.5M1.06B2%
Total Debt18.6M118M16%
FUNDAMENTALS RATINGS
MDGL: Fundamental Ratings
MDGL
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
40
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CADLMDGL
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
82%
MACD
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
79%
Advances
ODDS (%)
Bullish Trend 9 days ago
85%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 5 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
76%
Aroon
ODDS (%)
Bullish Trend 3 days ago
72%
Bearish Trend 3 days ago
77%
View a ticker or compare two or three
Ad is loading...
CADL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MDGL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MXYKX6.44N/A
N/A
Empower T. Rowe Price Mid Cp Gr Instl
PJFQX68.96N/A
N/A
PGIM Jennison Growth R6
WISNX12.51-0.02
-0.16%
William Blair International Sm Cap Gr N
SSCDX16.75-0.10
-0.59%
Sit Small Cap Dividend Growth I
SVIFX10.75-0.09
-0.83%
Virtus Ceredex Large-Cap Value Equity C

CADL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CADL has been loosely correlated with INKT. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CADL jumps, then INKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CADL
1D Price
Change %
CADL100%
+3.62%
INKT - CADL
37%
Loosely correlated
-1.15%
MDGL - CADL
33%
Poorly correlated
+0.31%
KRRO - CADL
31%
Poorly correlated
+0.25%
TCBP - CADL
27%
Poorly correlated
+4.60%
GTHX - CADL
27%
Poorly correlated
N/A
More

MDGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDGL has been loosely correlated with KA. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if MDGL jumps, then KA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDGL
1D Price
Change %
MDGL100%
+0.31%
KA - MDGL
62%
Loosely correlated
+8.02%
VXRT - MDGL
61%
Loosely correlated
+2.97%
VBIVQ - MDGL
57%
Loosely correlated
-11.25%
ALXO - MDGL
56%
Loosely correlated
-3.16%
REPL - MDGL
55%
Loosely correlated
+2.59%
More